• MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of "Moderate Buy" by Analysts

    المصدر: Buzz FX / 23 نوفمبر 2024 02:46:08   America/New_York


    MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Shares of MoonLake Immunotherapeutics ( NASDAQ:MLTX - Get Free Repo
    Read more...
شارك على،